# PDX1

## Overview
PDX1, or pancreatic and duodenal homeobox 1, is a gene that encodes a transcription factor crucial for pancreatic development and the function of β-cells. The protein encoded by PDX1 is characterized by a homeodomain, which facilitates its role in DNA binding and regulation of gene expression, particularly genes involved in insulin production (Kishi2003Sumoylation). As a transcription factor, PDX1 is integral to the development of the pancreas and the maintenance of glucose homeostasis, influencing the differentiation of pancreatic progenitors and the function of mature β-cells (Ebrahim2022PDX1). The activity and stability of the PDX1 protein are modulated by various post-translational modifications, including phosphorylation, sumoylation, and methylation, which are essential for its regulatory functions (Maganti2015Transcriptional; Boucher2006Phosphorylation; Kishi2003Sumoylation). Mutations in the PDX1 gene are associated with several metabolic disorders, including maturity-onset diabetes of the young 4 (MODY4) and neonatal diabetes, highlighting its clinical significance in maintaining pancreatic function and glucose regulation (Ebrahim2022PDX1; ForeroCastro2023Clinical).

## Structure
PDX1, or pancreatic and duodenal homeobox 1, is a transcription factor essential for pancreatic development and β-cell function. The protein contains a homeodomain, a 60-amino acid helix-turn-helix motif, which facilitates DNA binding. This domain is crucial for its role in regulating gene expression related to insulin production (Kishi2003Sumoylation). PDX1 also includes a transactivation domain, which is involved in enhancing transcriptional activity, and a C-terminal domain that contributes to its functional diversity (Maganti2015Transcriptional).

Post-translational modifications play a significant role in regulating PDX1's activity and stability. Phosphorylation of specific serine residues, such as Ser 61 and Ser 66, marks the protein for degradation via a glycogen synthase kinase 3 (GSK3)-dependent mechanism, affecting its stability and function in β-cells (Boucher2006Phosphorylation). Sumoylation, involving the attachment of SUMO-1, is critical for PDX1's nuclear localization and stability, enhancing its transcriptional activity on the insulin promoter (Kishi2003Sumoylation). Lysine methylation, particularly at Lys-131, further augments PDX1's transcriptional activity, highlighting the importance of these modifications in its regulatory functions (Maganti2015Transcriptional).

PDX1 has several splice variants, which contribute to its functional diversity, although specific details on these isoforms are not provided in the context.

## Function
The PDX1 gene encodes a transcription factor that is crucial for the development and function of pancreatic β-cells. In healthy human cells, PDX1 is predominantly expressed in β-cells and plays a significant role in regulating insulin gene expression, particularly in response to glucose levels. It binds to the insulin gene promoter, activating its transcription, which is essential for maintaining glucose homeostasis (Ebrahim2022PDX1). PDX1 also regulates other pancreas-associated genes, such as those for somatostatin, glucokinase, and islet amyloid polypeptide, contributing to the overall function of the pancreas (Ebrahim2022PDX1).

PDX1 is involved in the early stages of pancreas development, influencing the differentiation of pancreatic progenitors into various cell types, including β-cells. It is part of a regulatory network with other transcription factors like SOX9 and FOXA2, which are crucial for the commitment of progenitors to glucose-responsive β-cells (Ebrahim2022PDX1). In mature β-cells, PDX1 helps maintain their identity and function, preventing them from adopting an α-cell phenotype (Ebrahim2022PDX1). The gene's activity is modulated by interactions with histone deacetylases and acetyltransferases, which affect chromatin structure and gene expression in response to glucose levels (Ebrahim2022PDX1).

## Clinical Significance
Mutations in the PDX1 gene are associated with several pancreatic and metabolic disorders. Homozygous mutations can result in pancreas agenesis, a condition characterized by the absence of the pancreas, leading to fatal perinatal hyperglycemia (Ebrahim2022PDX1). Heterozygous mutations in PDX1 are linked to maturity-onset diabetes of the young 4 (MODY4), a monogenic form of diabetes mellitus (Ebrahim2022PDX1; Stoffers1998Insulin). Specific point mutations, such as P33T and C18R, impair β-cell development and function, increasing the risk of diabetes by affecting insulin synthesis and secretion (Wang2019Point).

In neonatal diabetes, mutations like PDX1 c.527G>A (p.Arg176Gln) and PDX1 c.571A>G (p.Lys191Glu) are implicated in pancreatic dysgenesis, leading to both endocrine and exocrine insufficiencies (ForeroCastro2023Clinical). In type 2 diabetes, reduced PDX1 expression and DNA methylation changes in the PDX1 promoter are linked to impaired insulin and GLUT2 expression, contributing to hyperglycemia (Ebrahim2022PDX1; Park2008Development). These genetic and epigenetic alterations underscore the critical role of PDX1 in maintaining normal pancreatic function and glucose homeostasis.

## Interactions
PDX1, a transcription factor crucial for pancreatic development and function, interacts with various proteins to regulate gene expression. It forms a trimeric complex with PBX1b and MRG1 (MEIS2) in pancreatic acinar cells, which is essential for the activity of the ELA1 transcriptional enhancer. This complex alters the transcriptional activity of PDX1, acting as a switch to change its function depending on the cellular context (Swift1998An).

PDX1 also interacts with the coactivator Bridge-1, which enhances its transcriptional activation capabilities. This interaction involves the amino-terminal domain of PDX1 and is crucial for modulating the transcription of pancreatic islet genes, including insulin and somatostatin (Stanojevic2005The).

In addition, PDX1 interacts with PCIF1, a nuclear factor containing TRAF and POZ domains, which inhibits PDX1's transactivation. This interaction is mediated by a conserved motif within the C-terminus of PDX1 and is significant for maintaining glucose homeostasis (Liu2006Two).

PDX1 also forms a transcriptional complex with ATF4 and ATF5, which is important for β cell survival under stress conditions. This complex regulates genes involved in stress responses and apoptosis, highlighting its role in β cell fate during stress (Juliana2018A).


## References


[1. (Maganti2015Transcriptional) Aarthi V. Maganti, Bernhard Maier, Sarah A. Tersey, Megan L. Sampley, Amber L. Mosley, Sabire Özcan, Boobalan Pachaiyappan, Patrick M. Woster, Chad S. Hunter, Roland Stein, and Raghavendra G. Mirmira. Transcriptional activity of the islet β cell factor pdx1 is augmented by lysine methylation catalyzed by the methyltransferase set7/9. Journal of Biological Chemistry, 290(15):9812–9822, April 2015. URL: http://dx.doi.org/10.1074/jbc.m114.616219, doi:10.1074/jbc.m114.616219. This article has 37 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m114.616219)

[2. (Stoffers1998Insulin) D A Stoffers, V Stanojevic, and J F Habener. Insulin promoter factor-1 gene mutation linked to early-onset type 2 diabetes mellitus directs expression of a dominant negative isoprotein. Journal of Clinical Investigation, 102(1):232–241, July 1998. URL: http://dx.doi.org/10.1172/jci2242, doi:10.1172/jci2242. This article has 139 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci2242)

[3. (Stanojevic2005The) Violeta Stanojevic, Kwok-Ming Yao, and Melissa K. Thomas. The coactivator bridge-1 increases transcriptional activation by pancreas duodenum homeobox-1 (pdx-1). Molecular and Cellular Endocrinology, 237(1–2):67–74, June 2005. URL: http://dx.doi.org/10.1016/j.mce.2005.03.003, doi:10.1016/j.mce.2005.03.003. This article has 25 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.mce.2005.03.003)

[4. (Juliana2018A) Christine A. Juliana, Juxiang Yang, Corey E. Cannon, Austin L. Good, Matthew W. Haemmerle, and Doris A. Stoffers. A pdx1-atf transcriptional complex governs β cell survival during stress. Molecular Metabolism, 17:39–48, November 2018. URL: http://dx.doi.org/10.1016/j.molmet.2018.07.007, doi:10.1016/j.molmet.2018.07.007. This article has 24 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.molmet.2018.07.007)

[5. (Ebrahim2022PDX1) Nour Ebrahim, Ksenia Shakirova, and Erdem Dashinimaev. Pdx1 is the cornerstone of pancreatic β-cell functions and identity. Frontiers in Molecular Biosciences, December 2022. URL: http://dx.doi.org/10.3389/fmolb.2022.1091757, doi:10.3389/fmolb.2022.1091757. This article has 29 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fmolb.2022.1091757)

[6. (Liu2006Two) Aihua Liu, Jennifer Oliver-Krasinski, and Doris A. Stoffers. Two conserved domains in pcif1 mediate interaction with pancreatic transcription factor pdx‐1. FEBS Letters, 580(28–29):6701–6706, November 2006. URL: http://dx.doi.org/10.1016/j.febslet.2006.11.021, doi:10.1016/j.febslet.2006.11.021. This article has 21 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.febslet.2006.11.021)

[7. (Kishi2003Sumoylation) Akio Kishi, Takaaki Nakamura, Yoshihiko Nishio, Hiroshi Maegawa, and Atsunori Kashiwagi. Sumoylation of pdx1 is associated with its nuclear localization and insulin gene activation. American Journal of Physiology-Endocrinology and Metabolism, 284(4):E830–E840, April 2003. URL: http://dx.doi.org/10.1152/ajpendo.00390.2002, doi:10.1152/ajpendo.00390.2002. This article has 75 citations.](https://doi.org/10.1152/ajpendo.00390.2002)

[8. (Wang2019Point) Xianming Wang, Michael Sterr, Ansarullah, Ingo Burtscher, Anika Böttcher, Julia Beckenbauer, Johanna Siehler, Thomas Meitinger, Hans-Ulrich Häring, Harald Staiger, Filippo M. Cernilogar, Gunnar Schotta, Martin Irmler, Johannes Beckers, Christopher V.E. Wright, Mostafa Bakhti, and Heiko Lickert. Point mutations in the pdx1 transactivation domain impair human β-cell development and function. Molecular Metabolism, 24:80–97, June 2019. URL: http://dx.doi.org/10.1016/j.molmet.2019.03.006, doi:10.1016/j.molmet.2019.03.006. This article has 64 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.molmet.2019.03.006)

[9. (Boucher2006Phosphorylation) Marie-Josée Boucher, Lars Selander, Lennart Carlsson, and Helena Edlund. Phosphorylation marks ipf1/pdx1 protein for degradation by glycogen synthase kinase 3-dependent mechanisms. Journal of Biological Chemistry, 281(10):6395–6403, March 2006. URL: http://dx.doi.org/10.1074/jbc.m511597200, doi:10.1074/jbc.m511597200. This article has 92 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m511597200)

[10. (Park2008Development) Jun H. Park, Doris A. Stoffers, Robert D. Nicholls, and Rebecca A. Simmons. Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of pdx1. Journal of Clinical Investigation, May 2008. URL: http://dx.doi.org/10.1172/jci33655, doi:10.1172/jci33655. This article has 64 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci33655)

[11. (Swift1998An) Galvin H. Swift, Ying Liu, Scott D. Rose, Larry J. Bischof, Scott Steelman, Arthur M. Buchberg, Christopher V. E. Wright, and Raymond J. MacDonald. An endocrine-exocrine switch in the activity of the pancreatic homeodomain protein pdx1 through formation of a trimeric complex with pbx1b and mrg1 (meis2). Molecular and Cellular Biology, 18(9):5109–5120, September 1998. URL: http://dx.doi.org/10.1128/mcb.18.9.5109, doi:10.1128/mcb.18.9.5109. This article has 132 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.18.9.5109)

[12. (ForeroCastro2023Clinical) Nicolas Forero-Castro, Luis Carlos Ramirez, Juan Carlos Celis, Fernando Arturo Silva Henao, and Fernando Leal Valencia. Clinical and molecular description of two cases of neonatal diabetes secondary to mutations in pdx1. Endocrinology, Diabetes &amp; Metabolism Case Reports, July 2023. URL: http://dx.doi.org/10.1530/edm-22-0383, doi:10.1530/edm-22-0383. This article has 1 citations.](https://doi.org/10.1530/edm-22-0383)